ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-1.09%
US Tech 100
20,563.20
-1.57%
S&P 500
6,040.53
-0.50%
US Dollar vs CAD
1.46737
-0.28%
Bitcoin
95,574.38
-2.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Poolbeg Pharma Plc (POLB) Share Price

Poolbeg Pharma Plc

Poolbeg Pharma Plc (POLB)

LSE
5.10
0.00
( 0.00% )
Updated: 02:00:00
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
5.10
Bid
5.00
Ask
5.20
Volume
98,566
5.10 Day's Range 5.10
3.60 52 Week Range 15.70
Market Cap
25.5M
Previous Close
5.10
Open
5.10
Last Trade
97265
@
5.078
(O)
Last Trade Time
02:33:39
Financial Volume
-
VWAP
-
Average Volume (3m)
2,254,416
Shares Outstanding
500,000,000
Dividend Yield
-
PE Ratio
-6.46
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-3.93M

About Poolbeg Pharma Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.poolbegpharma.com
Headquarters
London, Gbr
Founded
-
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 5.10p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 3.60p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares outstanding. The market capitalization of Poolbeg Pharma is £25.50 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -6.46.

Ask ADVFN Intelligence (AI)

POLB Latest News

More News

J & E Davy (UK) Limited Form 8.5 - Poolbeg Pharma Plc

J & E Davy (UK) Limited 31 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 31 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 Poolbeg Pharma Plc

J & E Davy (UK) Limited 30 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 30 2025
RNS Regulatory News

Poolbeg Pharma PLC Offer Update - Extension to PUSU Deadline

Poolbeg Pharma PLC 30 January 2025     NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD...

January 30 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 Poolbeg Pharma Plc

J & E Davy (UK) Limited 29 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 29 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5- Poolbeg Pharma PLC

J & E Davy (UK) Limited 28 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 28 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 (EPT/NON-RI)

J & E Davy (UK) Limited 24 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 24 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 (EPT/NON-RI)

J & E Davy (UK) Limited 23 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 23 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 (EPT/NON-RI)

J & E Davy (UK) Limited 22 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 22 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 (EPT/NON-RI)

J & E Davy (UK) Limited 22 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 22 2025
RNS Regulatory News

J & E Davy (UK) Limited Form 8.5 (EPT/NON-RI)

J & E Davy (UK) Limited 22 January 2025   FORM 8.5 (EPT/NON-RI)   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI...

January 22 2025
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.25-4.672897196265.355.65.112540125.35570344DE
40.921.42857142864.25.753.633030444.73905891DE
12-3.8-42.69662921358.98.93.622544165.22374637DE
26-6.75-56.962025316511.85133.616055606.77982304DE
52-3.85-43.01675977658.9515.73.617686119.49169188DE
156-2.53-33.15858453477.6315.73.614470498.36374957DE
260-5.9-53.63636363641115.73.613833338.60584074DE

POLB - Frequently Asked Questions (FAQ)

What is the current Poolbeg Pharma share price?
The current share price of Poolbeg Pharma is 5.10p
How many Poolbeg Pharma shares are in issue?
Poolbeg Pharma has 500,000,000 shares in issue
What is the market cap of Poolbeg Pharma?
The market capitalisation of Poolbeg Pharma is GBP 25.5M
What is the 1 year trading range for Poolbeg Pharma share price?
Poolbeg Pharma has traded in the range of 3.60p to 15.70p during the past year
What is the PE ratio of Poolbeg Pharma?
The price to earnings ratio of Poolbeg Pharma is -6.46
What is the reporting currency for Poolbeg Pharma?
Poolbeg Pharma reports financial results in GBP
What is the latest annual profit for Poolbeg Pharma?
The latest annual profit of Poolbeg Pharma is GBP -3.93M
What is the registered address of Poolbeg Pharma?
The registered address for Poolbeg Pharma is 40 BANK STREET, FLOOR 24, LONDON, E14 5NR
What is the Poolbeg Pharma website address?
The website address for Poolbeg Pharma is www.poolbegpharma.com
Which industry sector does Poolbeg Pharma operate in?
Poolbeg Pharma operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SYMESupply@me Capital Plc
0.0034p
(15.25%)
122.41M
HDDHardide Plc
6.75p
(14.41%)
478.24k
GKPGulf Keystone Petroleum Ltd
193.00p
(13.13%)
1.58M
EMEEmpyrean Energy Plc
0.14p
(12.00%)
157.5M
SCGLSealand Capital Galaxy Limited
7.00p
(12.00%)
3.14M
LLAILunglife Ai Inc
2.15p
(-79.02%)
2.74M
SDYSpeedy Hire Plc
19.60p
(-28.73%)
7.83M
CASSCassell Capital Plc
0.075p
(-22.68%)
8.58M
PNNPennon Group Plc
451.00p
(-21.97%)
733.88k
ORROriole Resources Plc
0.205p
(-21.61%)
92.13M
MSMNMosman Oil And Gas Limited
0.0435p
(8.75%)
1.1B
NTVONativo Resources Plc
0.0018p
(0.00%)
589.5M
TRPTower Resources Plc
0.0295p
(0.00%)
296.83M
EMEEmpyrean Energy Plc
0.14p
(12.00%)
157.5M
SYMESupply@me Capital Plc
0.0034p
(15.25%)
122.41M

Discussion

View Full Feed
JuicePigs JuicePigs 4 minutes ago
Lakota has been dumping all of his shares the last few days. That's why it shows so many"sells"... he chose the coward way out of selling everything quietly, deleting all of his recent comments, and showing himself the exit.... shamful really. 
WDLF
uranium-pinto-beans uranium-pinto-beans 4 minutes ago
BAC
Bank of America added to US Conviction List at Goldman Sachs
Goldman Sachs analysts added Bank of America to the firm's US Conviction List as part of its monthly update. Goldman believes Bank of America is positioned for steady net interest income expansion as it reprices loans
uranium-pinto-beans uranium-pinto-beans 5 minutes ago
SPT
Sprout Social price target raised to $42 from $34 at Jefferies
Jefferies raised the firm's price target on Sprout Social to $42 from $34 and keeps a Buy rating on the shares as part of a Q4 earnings preview. The firm lowered fiscal 2025 revenue estimates on currency headwinds, b
SPT
Woodpecker3 Woodpecker3 7 minutes ago
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On December 6, 2024, Society Pass Incorporated (the “Company”) received a letter (the “Nasdaq Staff Letter”) from The Nasdaq Stock Market LLC
(“Nasdaq”) indicating that, for the last th
SOPA
ksquared ksquared 8 minutes ago
Good Morning, All.
Here's to another blessed day on Mother Earth. Have fun.
baltimorebullet baltimorebullet 9 minutes ago
You should have started your post with IMHO.
AVXL
Unabel2020 Unabel2020 11 minutes ago
Who thinks he will sell soon? Why or why not ? I want to know everyone’s perception ? Would it benefit him more to keep it or sell it?
JADA
TAKURI TAKURI 12 minutes ago
Total supply589.5T SHIB
SHIBUSD
MasterBlastr MasterBlastr 14 minutes ago
LMFAO @ The Orange Clown.
GWAV
chicks0123 chicks0123 14 minutes ago
Good morning CLNVERS 
CLNV
TAKURI TAKURI 15 minutes ago
Very soon 0,00001
SHIBUSD
starman2 starman2 29 minutes ago
With the imbecile in the WH tanking the markets today, and the earnings after close, I'm predicting a sharp pullback this week. Unless earnings revenue is over 30% and guidance is exceptional, I see nothing but red.
PLTR
Methinks Methinks 32 minutes ago
https://venturebeat.com/security/the-ai-paradox-how-tomorrows-cutting-edge-tools-can-become-dangerous-cyber-threats-and-how-to-prepare/
AI is a threat - so use Wave.
Methinks Methinks 35 minutes ago
https://www.businessnewsaustralia.com/articles/human-error--an-overlooked-cyber-risk-for-smes.html
Protect these humans - with Wave.
Methinks Methinks 37 minutes ago
https://www.entrepreneur.com/en-gb/entrepreneurs/the-silent-victims-of-cybercrime-how-one-startup-is/486414
The "silent victims" should be protected - with Wave.
primecomm primecomm 39 minutes ago
Good Morning $GRLF
GRLF
gt1217 gt1217 43 minutes ago
The situation with Canada and Mexico will change. Trump speaks with both of them today. Something will come out of it and the whole situation will change. Trump will stand his ground but will be willing to adjust the tariffs on a sliding scale. Must do this to reduce that if you don't than they stay
XRPUSD
floridaboy floridaboy 44 minutes ago
Quarterly report for SAPX due 2/15... They'll need two quarterly reports filed to get current
SAPX
capgain capgain 46 minutes ago
Thanks, I told her you guys said Happy Birthday. She said IHUB huh lol
NoBody NoBody 47 minutes ago
Is this finally waking up.  Seems a bit more activity than a month ago.  I am anxious to see what the 12/31 numbers show???
FHLD
capgain capgain 49 minutes ago
GM, Larry. I figured something was going to happen there sooner than later. Go Trump!
dennisdave dennisdave 50 minutes ago
You won't sell because your a short
Yawn 🥱

I really wish a short I would have turned my position now and pocketed a huge profit, but alas I own more shares than you (unfortunately).

NWBO groupie zealots cant stand reality, so reality is a short now
NWBO

Your Recent History

LSE
POLB
Poolbeg Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads